Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis

References

• Kasiotis KM, Pratsinis H, Kletsas D, et al. Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food ChemToxicol. 2013;61:112–120.
   Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Pangeni R, Sahni JK, Ali J, et al. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv. 2014;11(8):1285–1298.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY, Ho PC. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and gluteraldehyde as the hardening agent for colonic specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target. 2011;19(6):446–457.
   PubMed Web of Science ®Google Scholar
• Jeong JB, Lee J, Lee SH. TCF4 is a molecular target of resveratrol in the prevention of colorectal cancer. IJMS. 2015;16(12):10411–10425.
   Google Scholar
• Negi P, Aggarwal M, Sharma G, et al. Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s). Biomed Pharmacother. 2017;88:480–487.
   PubMed Web of Science ®Google Scholar
• Zu Y, Zhang Y, Wang W, et al. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles. Drug Deliv. 2016;23(3):981–991.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY. Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier. Int J Pharm. 2010;35:20–28.
   Google Scholar
• Gabriel DP, McClements DJ. Resveratrol encapsulation: designing delivery resveratrol encapsulation: designing delivery systems to overcome solubility, stability and bioavailability issues. Trends Food Sci Technol. 2014;38:88–103.
   Web of Science ®Google Scholar
• Bonechi C, Martini S, Ciani L. Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol. PLoS One. 2011;7:1–11.
   Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical application of cyclodextrins. Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017–1025.
   PubMed Web of Science ®Google Scholar
• Peng H, Xiong H, Li J, et al. Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. J food Chem. 2010;121(1):23–28.
   Web of Science ®Google Scholar
• Pando D, Gutiérrez G, Coca J, et al. Preparation and characterization of niosomes containing resveratrol. J Food Eng. 2013;117(2):227–234.
   Web of Science ®Google Scholar
• Ahmed RZ, Patil G, Zaheer Z. Nanosponges- a completely new nano-horizon: pharmaceutical applications and recent advances. Drug Dev. Ind. Pharm. 2013;39(9):1263–1272.
   PubMed Web of Science ®Google Scholar
• Osmani RAM, Aloorkar NH. Microsponge based drug delivery system for augmented gastroparesis therapy: Formulation development and evaluation. Asian J Pharm Sci. 2015;10:442–451.
   Web of Science ®Google Scholar
• Nief RA, Hussein AA. Preparation and evaluation of meloxicam microsponges as transdermal delivery system. Iraqi J Pharm Sci. 2014;23(2):62–74.
   Google Scholar
• Srivastava R, Kumar D, Pathak K. Colonic Luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm. 2012;427(2):153–162.
   PubMedGoogle Scholar
• Maheshwari R, Sharma P, Tekade M, et al. Microsponge embedded tablets for sustained delivery of nifedipine. Pharm Nanotechnol. 2017;5(3):192–202.
   PubMedGoogle Scholar
• Ashord M, Fell JT, Attwood D. An evaluation of pectin as a carrier for drug targeting to the colon. J Control Release. 1993;26:213–220.
   Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, et al. Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen. Int J Pharm. 2015;485(1-2):365–373.
   PubMedGoogle Scholar
• Kumar V, Soni GC, Prajapati SK. Sustained release hydrophilic matrix tablet of ibuprofen: influence of polymers on in vitro release and bioavailability. Int J Pharm Res Sci. 2012;1(4):69–83.
   Google Scholar
• Rathore C, Jain N, Garg N. Polysaccharide-microsponge based matrix tablet for colon targeting of ketoprofen: in vitro and in vivo evidence. IJPSR. 2017;8(10):4250–4260.
   Google Scholar
• Perge L, Robitzer M, Guillemot C, et al. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study. Int J Pharm. 2012;422(1–2):59–67.
   PubMed Web of Science ®Google Scholar
• Shinde AJ, Paithane MB, Sawant SS. Development and evaluation of fenoprofen microsponges and its colonic delivery using natural polysaccharides. Asian J Pharm Sci Nanotechnol. 2014;1(27):42–30.
   Google Scholar
• Devrim B, Canefe K. Preparation and evaluation of modified release ibuprofenmicrospheres with acrylic polymers (Eudragit®) by quasiemulsion solvent diffusion method: effect of variables. Acta Pol Pharm Drug Res. 2006;63:521–534.
   PubMedGoogle Scholar
• Anwer MK, Al-Shdefat R, Ezzeldin E, et al. Preparation, evaluation and bioavailability studies of Eudragit coated PLGA nanoparticles for sustained release of eluxadoline for the treatment of irritable bowel syndrome. Frontiers in Pharmacol. 2017;8:844.
   PubMed Web of Science ®Google Scholar
• Negi P, Singh B, Sharma G, et al. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv. 2016;23(3):941–957.
   Web of Science ®Google Scholar
• Zu Y, Zhang Y, Wang W, et al. Preparation and in vitro/ in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles. Drug Delivery. 2014;1–11.
   Google Scholar
• Malipeddi VR, Awasthi R, Dua K. Formulation and evaluation of controlled-release matrix systems of ciprofloxacin. Polim Med. 2017;47(2):101–10628.
   Google Scholar
• Sareen R, Nath K, Jain N, et al. Curcumin loaded microsponges for colon targeting in-flammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamics evaluation. BioMed Research Int. 2014;2014:1–7..
   Google Scholar
• Indian Pharmacopoeia (IP). 2014. Government of India Ministry of Health & Family Welfare, The Indian Pharmacopoeia Commission. Ghaziabad. 2014: II: p. 1864–1866.
   Google Scholar
• Tahan G, Aytac E, Aytekin H. Vitamin E has a dual effect of anti-infammatory and anti-oxidat activities in acetic-acid induced colitis in rats. Can J Surg. 2011;54(5):333–338.
   Google Scholar
• Murad HAS, Abdallah HM, Ali SS. Mentha longifolia protects against acetic acid induced colitis in rats. J Ethnopharm. 2016;1–22.
   Google Scholar
• Singh B, Kapil R, Nandi M. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv. 2011;8:1341–1360.
   Google Scholar
• Fernanda MC, Ana DS, Raul CE. Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci. 2014;9:27–34.
   Google Scholar
• Gupta A, Tiwari G, Tiwari R, et al. Enteric coated HPMC capsules plugged with 5-FU loaded microsponges: a potential approach for treatment of colon cancer. Braz J Pharm Sci. 2015;51(3):591–605..
   Google Scholar
• Esiringu F, Demiroz FT, Acarturk F. Investigation of the effect of intracolonic melatonin gel formulation on acetic acid-induce colitis. Drug Deliv. 2014;1–9.
   Google Scholar